The effect of chitosan as internal or external coating on the 5-ASA release from calcium alginate microparticles

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1294-1305

  Tapia, Cristián ^a   Molina, Sergio ^a   Diaz, Alvaro ^a   Abugoch, Lilian ^a   Diaz Dosque, Mario ^a   Valenzuela, Fernando ^a   Yazdani Pedram, Mehrdad ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

5 ASA; chitosan alginate; colonic drug delivery; delayed drug release; microparticles

Indexed keywords

BETA GLUCOSIDASE; CALCIUM ALGINATE; CHITOSAN; MESALAZINE; PHOSPHATE;

ACIDITY; ARTICLE; CONTROLLED STUDY; DELAYED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; IMMERSION; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; THERMOGRAVIMETRY; X RAY DIFFRACTION;

ALGINATES; AMINOSALICYLIC ACIDS; CAPSULES; COATED MATERIALS, BIOCOMPATIBLE; CYSTINE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; DRUG IMPLANTS; GLUCURONIC ACID; HEXURONIC ACIDS;

EID: 78649905470     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9504-y     Document Type: Article

References (21)

1. TF Vandamme A Lenourry C Charrueau J-C Chaumeil 2002 The use of polysaccharides to target drugs to the colon Carbohydr Polym 48 219 231 1:CAS:528:DC%2BD38XhtFGrtb0%3D 10.1016/S0144-8617(01)00263-6 (Pubitemid 34141159)
2. JH Park G Saravanakumar K Kim IC Kwon 2010 Targeted delivery of low molecular drugs using chitosan and its derivatives Adv Drug Deliv Rev 62 28 41 1:CAS:528:DC%2BC3cXhtlehsrw%3D 10.1016/j.addr.2009.10.003 19874862
3. MS Crcarevska MG Dodov K Goracinova 2008 Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa Eur J Pharm Biopharm 68 565 578 10.1016/j.ejpb.2007.06.007 (Pubitemid 351318191)
4. K Mladenovska O Cruaud P Richomme E Belamie RS Raicki M-C Venier-Julienne, et al. 2007 5-ASA loaded chitosan-Ca-alginate microparticles: preparation and physicochemical characterization Int J Pharm 345 59 69 1:CAS:528:DC%2BD2sXhtlWnt7rI 10.1016/j.ijpharm.2007.05.059 17616284 (Pubitemid 350087541)
5. K Mladenovska SR Raicki EI Janevik T Ristoski MJ Pavlova Z Kavrakovski, et al. 2007 Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles Int J Pharm 342 124 136 1:CAS:528: DC%2BD2sXptFymtrw%3D 10.1016/j.ijpharm.2007.05.028 17590293 (Pubitemid 47259341)
6. RM Lucinda-Silva HRN Salgado RC Evangelista 2010 Alginate-chitosan systems: in vitro controlled release of triamcinolone and in vivo gastrointestinal transit Carbohydr Polym 81 260 268 1:CAS:528: DC%2BC3cXlsFCisLk%3D 10.1016/j.carbpol.2010.02.016
7. S Wittaya-Areekul J Kruenate C Prahsarn 2006 Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone Int J Pharm 312 113 118 1:CAS:528:DC%2BD28XisFeqs7c%3D 10.1016/j.ijpharm.2006.01.003 16490331
8. AW Basit EL McConnell HM Fadda 2008 Gut instincts: explorations in intestinal physiology and drug delivery Int J Pharm 364 213 226 10.1016/j.ijpharm.2008.05.012 18602774
9. EL McConnell MD Short AW Basit 2008 An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man J Control Release 130 154 160 1:CAS:528:DC%2BD1cXhtVais7rP 10.1016/j.jconrel. 2008.05.022 18639950
10. H Tozaki T Odoriba N Okada T Fujita A Terabe T Suzuki, et al. 2002 Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats J Control Rel 82 51 61 1:CAS:528:DC%2BD38XltVOltbY%3D 10.1016/S0168-3659(02)00084-6 (Pubitemid 34775047)
11. EL McConnell S Murdan AW Basit 2008 An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria J Pharm Sci 97 3820 3829 1:CAS:528:DC%2BD1cXhtVyltL%2FM 10.1002/jps.21271 18186460
12. O Gaserod O Smidsrod G Skjak-Braek 1998 Microcapsules of alginate chitosan I. A quantitative study of the interaction between alginate and chitosan Biomaterials 19 1815 1825 1:CAS:528:DyaK1cXnvVKktr8%3D 10.1016/S0142-9612(98)00073-8 9855182 (Pubitemid 28519963)
13. X Liu W Xue Q Liu W Yu Y Fu X Xiong, et al. 2004 Swelling behaviour of alginate-chitosan microcapsules prepared by external gelation or internal gelation technology Carbohydr Polym 56 459 464 1:CAS:528:DC%2BD2cXkvFyku7s%3D 10.1016/j.carbpol.2004.03.011
14. C Tapia V Montezuma M Yazdani-Pedram 2008 Microencapsulation by spray coagulation of diltiazem HCl in calcium alginate-coated chitosan AAPS PharmSciTech 9 1198 1206 1:CAS:528:DC%2BC3cXovFanu7Y%3D 10.1208/s12249-008-9164- 3 19082741
15. Guidelines for stability testing of pharmaceutical products containing well established drug substances in conventional dosage forms. (Informe N°34: WHO Expert Committee on Specifications for Pharmaceutical Preparations).
16. C Tapia V Corbalán E Costa MN Gai M Yazdani-Pedram 2005 Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosan-carrageenan mixtures Biomacromolecules 6 2389 2395 1:CAS:528:DC%2BD2MXks1Khurs%3D 10.1021/bm050227s 16153073 (Pubitemid 41388248)
17. The United States Pharmacopeia 27, 27th Rev. United States Pharmacopeial Convention: Rockville; 2004.
18. 2 Pharm Res 15 889 896 1:CAS:528:DyaK1cXjvFWltrw%3D 10.1023/A:1011976615750 9647355 (Pubitemid 28307831)
19. C Tapia E Costa M Moris J Sapag-Hagar F Valenzuela C Basualto 2002 Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures chitosan-alginate Drug Dev Ind Pharm 28 217 224 1:CAS:528:DC%2BD38Xit1Kgu7s%3D 10.1081/DDC-120002455 11926366 (Pubitemid 34218786)
20. JP Soares JE Santso GO Chierice ETG Cavalheiro 2004 Thermal behavior of alginic acid and its sodium salt Eclectica Quím 29 57 63 1:CAS:528:DC%2BD2MXjtVWgtbo%3D
21. LD Brucec HS Navnit AW Malick MH Infeld JW McGinity 2005 Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid Eur J Pharm Biopharm 59 85 97 10.1016/j.ejpb.2004.06.007 (Pubitemid 39573440)